Psychiatry

Back to articles

Adding esketamine to oral therapy for treatment-resistant depression

KEY POINT

A trial published in the American Journal of Psychiatry suggests that adding esketamine (Spravato—Janssen) to an antidepressant for those with treatment-resistant depression (TRD) is more effective than giving an oral antidepressant alone.